Hemostemix on SPi NewsFollow our SPi News RSS Feed for hemostemix

Featured hemostemix News

[31 Oct 2019] Hemostemix Provides Corporate Update

[21 Oct 2019] Hemostemix Announces Positive Results and Conclusions Reported in Phase II CLI Trial Abstract

[17 Oct 2019] Hemostemix Announces Commencement of Arbitration

[01 Aug 2019] Hemostemix Announces $2 Million Loan Facility

[11 Jul 2019] Hemostemix Announces Financing Update and Interim CFO Appointment

[02 Jul 2019] Hemostemix Announces Ongoing Phase II CLI Trial Abstract Accepted for Presentation by Canadian Society for Vascular Surgery

[27 Jun 2019] Hemostemix Announces Enrollment Update for the ACP-01 Phase II Critical Limb Ischemia Clinical Trial

[25 Jun 2019] Hemostemix Announces Resignation of CFO

[16 May 2019] Hemostemix Closes First Tranche of Financing

[03 May 2019] Hemostemix Announces Convertible Debenture Financing

[15 Apr 2019] Hemostemix Announces Convertible Debenture Financing

[01 Apr 2019] Hemostemix Announces Appointment of Experienced Chief Medical Officer & President

[25 Feb 2019] Hemostemix Announces UC Davis Health Added as a Trial Site for Phase II Clinical Trial

[04 Feb 2019] Hemostemix Announces Submission of Orphan Drug Designation Application to the FDA

[17 Jan 2019] Hemostemix Provides Highlights of 2018 Accomplishments

[03 Jan 2019] Hemostemix Announces Two Additional Sites Enrolled in Phase II Clinical Trial

[09 Nov 2018] Hemostemix Announces Development of an ACP-01 Allogeneic Process and Initiation of R&D for Autologous NCP-01 Neural Cellular Precursors

[08 Nov 2018] Hemostemix Announces Important Manufacturing Process Refinements

[07 Nov 2018] Hemostemix Announces Three Additional Sites Enrolled in Phase II Clinical Trial

[30 Oct 2018] Hemostemix Announces OTCQB Listing and DTC Eligibility

[09 Oct 2018] Hemostemix Announces Three Additional Sites Enrolled in Phase II Clinical Trial

[27 Sep 2018] Hemostemix Announces Voting Results of the Annual and Special Meeting of Shareholders

[24 Sep 2018] Hemostemix Announces Addition to Its Clinical Trial Management Team

[16 Aug 2018] Hemostemix Announces Two New Strategic Trial Sites in Texas

[18 Jul 2018] Hemostemix Announces First U.S. Patients Treated in Phase II Clinical Trial

[05 Jul 2018] Hemostemix Formalizes World-Class Scientific Advisory Board

[30 May 2018] Hemostemix Announces Major Milestone Achieved With First 3 U.S. Trial Sites for Phase II Clinical Trial Open for Patient Enrollment

[23 May 2018] Hemostemix Announces New EU Patent Grant

[03 May 2018] Hemostemix Announces First Patient Treated in Phase II Clinical Trial

[27 Apr 2018] Hemostemix Announces Trial Site for Phase II Clinical Trial

[19 Apr 2018] Hemostemix Announces US FDA Clinical Trial Approval

[23 Feb 2018] Hemostemix Signs License Agreement with Aspire Health Science

[22 Feb 2018] Hemostemix Signs Manufacturing Agreement with Aspire Health Science

[20 Dec 2017] Hemostemix Receives Health Canada Clearance to Continue with Critical Limb Ischemia Clinical Trials

[26 Sep 2017] Hemostemix Announces Agreement with CRO Service Provider Topstone Research

[25 Aug 2017] Hemostemix Completes Private Placement and Rights Offering

[17 Aug 2017] Hemostemix Inc. Announces Agreement to Resolve all Outstanding Matters with Hemostemix (Asia) Corporation (HEMA)


Still looking?

Type in your search term below and click Enter

World News from SPi

Sector Publishing Intelligence [SPi'] publishes financial news from around the world FAST. For breaking news announcements from companies, blogs and commentators, SPi provides up to the minute, integrated news on all aspects of financial markets and financial services.

SPi's extensive database of corporate information shows company details alongside breaking corporate news from the world’s largest news providers.

Publish Your Stories with SPI

Please click here to find out how to submit press releases and articles for publication.

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us